UK food regulators have lowered the recommended safe daily dose of cannabidiol (CBD), a cannabis extract present in many different High Street products, including drinks and snacks.
By Michelle Roberts
Extracts
UK food regulators have lowered the recommended safe daily dose of cannabidiol (CBD), a cannabis extract present in many different High Street products, including drinks and snacks.
The Food Standards Agency says the advice is precautionary, following concerns long-term use might cause liver and other health problems.
Adults are being advised to have no more than 10 milligrams of CBD a day.
The previous recommended safe daily dose, from 2020, was 70 milligrams.
And the FSA is warning some products available in shops and online contain more than 10 milligrams of CBD per serving, which is about four to five drops of 5% CBD oil.
Derived from cannabis but without psychoactive properties, CBD is sold in some pharmacies and health-food shops as a supplement and used to treat conditions such as pain or insomnia.
CBD products can be sold as:
- oils
- drops, tinctures and sprays
- gel capsules
- sweets and confectionery
- bread and other bakery goods
- drinks
Certain groups of people – including children, pregnant women and people taking other medications – are advised not to use CBD.
“The more CBD you consume over your lifetime, the more likely you are to develop long-term adverse effects, like liver damage or thyroid issues. “The level of risk is related to how much you take, in the same way it is with some other potentially harmful products such as alcoholic drinks.”
Prof Robin May, FSA chief scientific advisor
Food Standards Scotland has issued the same advice.
We understand that this change to our advice will have implications for products currently on the market that contain more than 10mg of CBD per serving. We will be working closely with industry to minimise the risk, to ensure consumers are not exposed to potentially harmful levels of CBD.”
Emily Miles, CEO of the FSA
The FSA has a list of CBD food products that are under review. Products on this list are not formally authorised for sale, they have not yet been fully assessed for safety, but they are linked to applications which are moving through the novel foods process.
Further information:
Cannabidiol (CBD) and cannabis use for medical purposes | The ME Association